Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects: "The TRANSLATE Study"
Phase of Trial: Phase IV
Latest Information Update: 19 Jan 2018
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Focal segmental glomerulosclerosis
- Focus Pharmacodynamics
- Acronyms TRANSLATE
- 11 Jan 2018 Status changed from recruiting to completed.
- 28 Oct 2015 New trial record